Mead Johnson Nutrition Company
 (MJN)

- NYSE
What's your position on ?
Bullish
Bearish
Why are you ish?
Skip
Post
You voted ish on Vote again
Posts appear on the My Feed page of subscribers to this ticker
Last vote:
  • Thu, Jan. 28, 9:23 AM
    | Thu, Jan. 28, 9:23 AM | 16 Comments
  • Thu, Jan. 28, 7:32 AM
    • Mead Johnson Nutrition (NYSE:MJN): Q4 EPS of $0.78 beats by $0.05.
    • Revenue of $967M (-11.3% Y/Y) in-line.
    • Shares +3.37% PM.
    • Press Release
    | Thu, Jan. 28, 7:32 AM
  • Wed, Jan. 27, 5:30 PM
    | Wed, Jan. 27, 5:30 PM | 18 Comments
  • Fri, Jan. 15, 12:10 PM
    • Varian Medical Systems (VAR -1.4%) assumed (analyst transition) with Outperform rating and $91 (21% upside) price target by Barrington Research.
    • Sucampo Pharmaceuticals (SCMP -6.5%) initiated with Sell rating and $7 (45% downside risk) price target by Empire.
    • Shire plc (SHPG -1.1%) upgraded to Outperform from Neutral by Credit Suisse. Price target reduced to ₤50 from ₤54.
    • Mead Johnson Nutrition (MJN -1.3%) downgraded to Neutral from Overweight by JP Morgan. Price target lowered to $77 (13% upside) from $85.
    | Fri, Jan. 15, 12:10 PM
  • Dec. 17, 2015, 11:02 AM
    • Target (NYSE:TGT) says the international version of its website has generated orders from shoppers in over 100 nations.
    • The website launched in October.
    • The top selling item so far is Enfamil Premium Infant Formula which could be seen as a positive development for maker Mead Johnson Nutrition (NYSE:MJN).
    | Dec. 17, 2015, 11:02 AM | 1 Comment
  • Dec. 3, 2015, 4:23 PM
    • Mead Johnson Nutrition (NYSE:MJN) declares $0.4125/share quarterly dividend, in line with previous.
    • Forward yield 2.08%
    • Payable Jan. 4; for shareholders of record Dec. 14; ex-div Dec. 10.
    | Dec. 3, 2015, 4:23 PM
  • Oct. 30, 2015, 9:03 AM
    • Goodbaby International (OTC:GBBYF) is up 10% since China announced it would end a one-child policy, while China Child Care Corp. (OTC:PFGHF) has shot up over 35%.
    • Japanese baby bottle maker Pigeon Corp. (OTC:PIGEF, OTCPK:PGENY) and diaper maker Unicharm (OTCPK:UNICY, OTCPK:UNCHF) are solidly higher in Tokyo.
    • Many local formula companies saw their stocks rose in Hong Kong trading, while Mead Johnson Nutrition (NYSE:MJN) was a favored play of U.S.-based investors. Disney (NYSE:DIS) and Kimberly-Clark (NYSE:KMB) are also getting some attention as multinationals that could benefit.
    • The big loser? Shares of condom maker Okamoto Industries are down sharply over the last two days.
    • There is plenty of disagreement from analysts on how much population in China will change due to the new policy.
    | Oct. 30, 2015, 9:03 AM | 7 Comments
  • Oct. 29, 2015, 9:08 AM
    • China will end a long-time policy of limiting families to one child, according to Xinhua News. No specific timetable was set.
    • The government has been slowly relaxing some of the rules around the restrictive policy.
    • Companies seen potentially getting a marginal benefit from the development over time if families become larger include Hasbro (NASDAQ:HAS), Mattel (NASDAQ:MAT), Danone (OTCQX:DANOY), Nestle (OTCPK:NSRGY, OTCPK:NSRGF), Procter & Gamble (NYSE:PG), and Mead Johnson Nutrition (NYSE:MJN). Add your own ideas in the comments stream.
    | Oct. 29, 2015, 9:08 AM | 31 Comments
  • Oct. 23, 2015, 7:27 AM
    • Diplomat Pharmacy (DPLO +2.3%) initiated with Buy rating and $35 (44% upside) price target by UBS.
    • Enanta (ENTA -1.2%) upgraded to Outperform from Market Perform by JMP Securities. Price target is $32 (36% upside).
    • ZS Pharma (ZSPH +3.2%) upgraded to Overweight from Equal Weight by Morgan Stanley. Price target raised to $76 (15% upside) from $67.
    • Pfizer (PFE +1.3%) upgraded to Outperform from Market Perform by Cowen and Company. Price target raised to $43 (27% upside) from $35.
    • Valeant Pharmaceuticals (VRX +9.1%) downgraded to Market Perform from Outperform by BMO Capital. Price target lowered to $141 (28% upside).
    • Mead Johnson (MJN +0.8%) downgraded to Neutral from Outperform by Credit Suisse. Price target is $86 (8% upside).
    • Community Health Systems (CYH +6.7%) downgraded to Neutral from Buy by BofA Merrill Lynch. Price target lowered to $42 (50% upside) from $64.
    | Oct. 23, 2015, 7:27 AM | 9 Comments
  • Oct. 22, 2015, 7:32 AM
    • Mead Johnson Nutrition (NYSE:MJN): Q3 EPS of $0.80 misses by $0.04.
    • Revenue of $977.5M (-10.3% Y/Y) misses by $42.5M.
    | Oct. 22, 2015, 7:32 AM
  • Oct. 21, 2015, 5:30 PM
    | Oct. 21, 2015, 5:30 PM | 25 Comments
  • Oct. 9, 2015, 10:15 AM
    • Gilead Sciences (GILD +0.5%) downgraded to Equal Weight from Overweight by Morgan Stanley. Price target maintained at $127 (27% upside).
    • Valeant Pharmaceuticals (VRX +3.3%) downgraded to Equal Weight from Overweight by Morgan Stanley. Price target lowered to $200 (14% upside) from $284.
    • Mead Johnson (MJN +0.7%) downgraded to Underperform from Neutral by BofA Merrill Lynch. Price target lowered to $78 (7% upside) from $80.
    • Ilumina (ILMN +1.9%) downgraded to Neutral from Buy by Mizuho Securities. Price target lowered to $150 (5% upside) from $250.
    • Chimerix (CMRX +1.7%) downgraded to Equal Weight from Overweight by Morgan Stanley. Price target lowered to $50 (34% upside) from $56.
    • Regeneron Pharmaceuticals (REGN +0.6%) downgraded to Equal Weight from Overweight with a price target of $593 (20% upside) by Morgan Stanley.
    • Diplomat Pharmacy (DPLO +1.1%) downgraded to Equal Weight from Overweight by Morgan Stanley. Price target lowered to $31 (24% upside) from $58.
    • AmerisourceBergen (ABC -0.3%) downgraded to Equal Weight from Overweight by Morgan Stanley. Price target lowered to $93 (0% upside) from $120.
    | Oct. 9, 2015, 10:15 AM | 54 Comments
  • Sep. 3, 2015, 9:13 AM
    • Mead Johnson Nutrition (NYSE:MJN) declares $0.4125/share quarterly dividend, in line with previous.
    • Forward yield 2.15%
    • Payable Oct. 1; for shareholders of record Sept. 14; ex-div Sept. 10.
    | Sep. 3, 2015, 9:13 AM
  • Jul. 28, 2015, 12:23 PM
    • Without admitting or denying guilt, Mead Johnson Nutrition (MJN +0.4%) agrees to pay $12,030,000 to the SEC to fully resolve its investigation into its promotional practices in China during the period 2008 - 2013. The inquiry was first disclosed by the company in 2013.
    | Jul. 28, 2015, 12:23 PM
  • Jul. 23, 2015, 12:08 PM
    • Mead Johnson Nutrition (MJN +2.1%) Q2 results ($M): Total Revenues: 1,032.4 (-7.1%); Operating Expenses: 446.8 (+1.7%); Net Income: 162.9 (-5.0%); EPS: 0.80 (-4.8%); CF Ops (6 mo.): 456.5 (+50.2%).
    • 2015 Guidance: Revenue growth: 0 - 2% from 7%; non-GAAP EPS: $3.63 - 3.78 from $3.90 - 4.00.
    | Jul. 23, 2015, 12:08 PM
  • Jul. 23, 2015, 7:34 AM
    • Mead Johnson Nutrition (NYSE:MJN): Q2 EPS of $0.76 misses by $0.01.
    • Revenue of $1.03B (-7.2% Y/Y) misses by $20M.
    | Jul. 23, 2015, 7:34 AM
Company Description
Mead Johnson Nutrition Co manufactures, distributes and sells infant formulas, children's nutrition and other pediatric nutritional products.